Torts (Products Liability; Causation)

Hymowitz v. Eli Lilly & Co. — Study Notes

Hymowitz v. Eli Lilly & Co., 73 N.Y.2d 487, 541 N.E.2d 128, 541 N.Y.S.2d 941 (Court of Appeals of New York 1989)

Study notes for Hymowitz v. Eli Lilly & Co.: professor notes, cold call prep, exam angles, and memory aids.

New York courts may apportion liability among DES manufacturers based on their national market shares when plaintiffs cannot identify a specific producer.
Professor Notes

The Hymowitz case is a landmark decision in product liability law, specifically addressing causation in situations involving fungible products, such as the synthetic hormone DES. The Court of Appeals' decision to adopt a national market-share liability approach addresses the challenge of proving which manufacturer was responsible for the injuries sustained by plaintiffs who were unknowingly exposed to a common drug. Professors will emphasize the implications of this ruling on tort law, including how it redefines traditional principles of causation and liability in the context of mass-produced goods. Additionally, the case explores the constitutionality of reviving certain time-barred claims, thereby engaging with the intersection of statutory law and tort law principles.

Furthermore, the decision disallows joint-and-several liabilities when it comes to absent market shares, which is significant for legal practitioners in navigating cases involving multiple potential tortfeasors. The approach adopted by the court helps facilitate justice for victims who could not otherwise identify the specific producer of the harmful product due to the nature of mass production and distribution. This case should serve as a prime example of judicial innovation in response to complex challenges in products liability litigation.

Cold Call Prep
  1. 1Explain the significance of the national market-share liability approach adopted by the court.
  2. 2What are the implications of reviving otherwise time-barred claims as decided in Hymowitz?
  3. 3How did the court address the issue of joint-and-several liability in this case?
  4. 4What were the potential constitutional concerns raised in Hymowitz v. Eli Lilly & Co.?
  5. 5Discuss how this case impacts future products liability claims involving fungible products.
Mnemonic Device

DES - Determine Exposure Share (highlighting the market-share liability concept).

Distinguish From
CaseDistinction
Joint & Several Liability CasesUnlike traditional joint-and-several liability cases, Hymowitz specifically rejects reallocation of absent market shares among defendants.
Baker v. JacksonBaker involved known tortfeasors where each party helped establish causation, while Hymowitz applies to fungible products where specific causation can't be determined.
Hoffman-La Roche, Inc. v. ZeltwangerHoffman-La Roche primarily examined direct product liability and negligence; Hymowitz deals with apportioning liability due to shared market dynamics.
Policy Arguments

For the Rule

The market-share liability approach promotes fairness and justice by allowing injured parties to recover damages when they cannot pinpoint a specific manufacturer.

Against the Rule

This approach may discourage manufacturers from maintaining high safety standards, as liability becomes more diluted among numerous producers.

Class Discussion Points
  • The evolution of liability standards in tort law and the implications of fungibility in product injuries.
  • The balance between consumer protection and the rights of manufacturers in the context of liability.
  • How the judiciary adapts legal frameworks in response to emerging challenges in product liability cases.
Exam Angle

This case is likely to appear on exams as a pivotal example of market-share liability and its application in product liability, particularly in the context of mass torts involving unidentifiable defendants.

Ace Your Cold Calls with Briefly

Get AI-powered case briefs, study notes, and cold call prep for every case in your casebook.